Lantero-Rodriguez, Juan
Vrillon, Agathe
Fernández-Lebrero, Aida
Ortiz-Romero, Paula
Snellman, Anniina
Montoliu-Gaya, Laia
Brum, Wagner S.
Cognat, Emmanuel
Dumurgier, Julien
Puig-Pijoan, Albert
Navalpotro-Gómez, Irene
García-Escobar, Greta
Karikari, Thomas K.
Vanmechelen, Eugeen
Ashton, Nicholas J.
Zetterberg, Henrik
Suárez-Calvet, Marc
Paquet, Claire
Blennow, Kaj
Article History
Received: 7 December 2022
Accepted: 28 February 2023
First Online: 10 March 2023
Declarations
:
: All patients or their legal relatives in case of severe dementia gave written informed consent to their participation in this study. Collection and analysis of samples were approved by the ethic committee of Bichat University, Paris, France (CEERB GHU Nord n°10-037) for Paris cohort and by the local ethics committee (CEIC PSMAR, project code 2018/7805I) for the BIODEGMAR cohort.
: Not applicable
: KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). MSC has served as a consultant and at advisory boards for Roche Diagnostics International Ltd and has given lectures in symposia sponsored by Roche Diagnostics, S.L.U and Roche Farma, S.A. MSC was granted with a project funded by Roche Diagnostics International Ltd; payments were made to the institution (BBRC). EVM is cofounder of ADx NeuroSciences.